JPS6340768B2 - - Google Patents

Info

Publication number
JPS6340768B2
JPS6340768B2 JP54002316A JP231679A JPS6340768B2 JP S6340768 B2 JPS6340768 B2 JP S6340768B2 JP 54002316 A JP54002316 A JP 54002316A JP 231679 A JP231679 A JP 231679A JP S6340768 B2 JPS6340768 B2 JP S6340768B2
Authority
JP
Japan
Prior art keywords
acid
compound
indole
methyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54002316A
Other languages
English (en)
Japanese (ja)
Other versions
JPS54100381A (en
Inventor
Nedoreku Ryushian
Gyoomu Jatsuku
Deyumon Kuroodo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of JPS54100381A publication Critical patent/JPS54100381A/ja
Publication of JPS6340768B2 publication Critical patent/JPS6340768B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP231679A 1978-01-16 1979-01-16 Drug composition of tetrahydropyridinyl indole derivative as base Granted JPS54100381A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801084A FR2426465B1 (en, 2012) 1978-01-16 1978-01-16

Publications (2)

Publication Number Publication Date
JPS54100381A JPS54100381A (en) 1979-08-08
JPS6340768B2 true JPS6340768B2 (en, 2012) 1988-08-12

Family

ID=9203493

Family Applications (1)

Application Number Title Priority Date Filing Date
JP231679A Granted JPS54100381A (en) 1978-01-16 1979-01-16 Drug composition of tetrahydropyridinyl indole derivative as base

Country Status (5)

Country Link
US (1) US4195081A (en, 2012)
EP (1) EP0003200B1 (en, 2012)
JP (1) JPS54100381A (en, 2012)
DE (1) DE2967615D1 (en, 2012)
FR (1) FR2426465B1 (en, 2012)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2477415A1 (fr) * 1980-03-07 1981-09-11 Roussel Uclaf Application a titre de medicaments de derives du tetrahydropyridin-4-yl indole et compositions les renfermant
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4742057A (en) * 1985-12-05 1988-05-03 Fujisawa Pharmaceutical Co., Ltd. Antiallergic thiazole compounds
US5846982A (en) * 1996-06-14 1998-12-08 Eli Lilly And Company Inhibition of serotonin reuptake

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2293931A1 (fr) * 1974-12-09 1976-07-09 Roussel Uclaf Application a titre de medicaments de derives du piperidyl-indole
FR2328468A2 (fr) * 1975-10-23 1977-05-20 Roussel Uclaf Application a titre de medicaments de derives du piperidyl-indole
JPS5283766A (en) * 1976-01-01 1977-07-12 Roussel Uclaf Piperidyl indole derivative and its salts and medicine comprising same

Also Published As

Publication number Publication date
EP0003200A3 (en) 1979-08-08
DE2967615D1 (en) 1986-09-18
FR2426465B1 (en, 2012) 1983-04-29
EP0003200B1 (fr) 1986-08-13
FR2426465A1 (en, 2012) 1979-12-21
EP0003200A2 (fr) 1979-07-25
JPS54100381A (en) 1979-08-08
US4195081A (en) 1980-03-25

Similar Documents

Publication Publication Date Title
AU570306B2 (en) 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts.
JP2775191B2 (ja) ５―クロロ―１―（４―フルオロフェニル） ―３―（１―（２― （２―イミダゾリジノン―１―イル）エチル） ―４―ピペリジル）―１ｈ―インドールまたはその薬学的に容認できる酸付加塩を使用する方法
US2770569A (en) Analgesic compositions
JPS6340792B2 (en, 2012)
DE2738646A1 (de) Neue piperidyl-indol-derivate und deren salze, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
CZ280879B6 (cs) Použití účinné látky flupirtinu pro odstranení svalového přepětí
JPH0313232B2 (en, 2012)
DE1420072B2 (de) (5'-Dibenzo- eckige Klammer auf a,e eckige Klammer zu -cycloheptatrienyliden)-piperidine, Verfahren zu ihrer Herstellung und Arzneimittel
DE60318306T2 (de) (1-indanon)-(1,2,3,6-tetrahydropyridin)derivat
TW201313708A (zh) 用於治療代謝性疾病與相關病症之單醯基甘油脂酶抑制劑
US6297262B1 (en) Treatment of schizophrenia and psychosis
HU190028B (en) Process for preparing pyridazine derivatives
JPS63185927A (ja) 薬物中毒治療のための医薬
JPS6340768B2 (en, 2012)
JPH02262580A (ja) チアゾリル又はオキサゾリル基で置換された１，２，５，６―テトラヒドロピリジンの新規の誘導体、それらの製造方法及び中間体、それらの薬剤としての使用並びにそれらを含有する組成物
CZ20013812A3 (cs) Pouľití saredutantu a jeho farmaceuticky přijatelných solí pro přípravu léčiva pouľitelného k léčení nebo prevenci poruch nálady, poruch adaptace nebo stavů úzkosti a deprese
US3125488A (en) Method of inducing analgesia by
TW200418823A (en) Novel compounds
JPH01110671A (ja) 新規の１，２，５，６−テトラヒドロピリジン−３−カルボキサアルデヒドのオキシムの誘導体、それらの製造方法、それらの薬剤としての使用及びそれらを含有する組成物
JPS5941992B2 (ja) チアキサンテン誘導体のアルファ異性体と該アルファ異性体の酸附加塩とを製造し且つ精製する方法
JPS6013767A (ja) ピリミジン誘導体
FR2460947A1 (fr) Nouveau derives n-substitues du tetrahydropyridinyl-indole, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
DE2951912A1 (de) Neues verfahren zur herstellung von piperidyl-indol-derivaten, hiernach erhaltene neue verbindung und deren salze, ihre anwendung als arzneimittel und die sie enthaltenden pharmazeutischen zusammensetzungen
US2817623A (en) Tabernanthine, ibogaine containing analgesic compositions
DE69226522T2 (de) Herstellung eines medikaments zur behandlung der drogenabhängigkeit